Suvanza Pharma, LLC
Limited financial coverage for SUVZ.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Suvanza Pharma, LLC is an emerging biotechnology enterprise dedicated to developing RapiDerm, an innovative drug delivery system applied to the skin, specifically targeting dermatological disorders. The company, which began operations in 2004 and is headquartered in Miami Beach, Florida, officially changed its name from Hamilton PNG to Suvanza Pharma, LLC in March 2010.
- CEO
- Nardo Zaias
- IPO
- 1995
- HQ
- Miami Beach, FL, US
Get TickerSpark's AI analysis on SUVZ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.60
- RSI (14)
- 48
- Avg Volume
- 599
No earnings-call transcripts are available for SUVZ yet.
- Free Float
- 0.0%
- Shares Outstanding
- 5.04B
- Float Shares
- 0
Our SUVZ coverage
Recent articles, reports, and earnings notes.
No research on SUVZ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SUVZ report →